THE PHAGE is a Tokyo-based digital-health startup founded in 2021 that builds personalized blood-glucose management on AI analysis of continuous glucose monitoring (CGM) data and daily lifestyle behavior. Its health-management app glucose flight pairs wearable CGM devices — including Japan's first official API integration with Abbott's FreeStyle Libre — with AI that predicts post-meal glucose spikes and generates individualized diet and exercise guidance, and it is offered to users through health insurance societies and municipalities. The company also provides research and development support to food and pharmaceutical companies, with partners such as Meiji, TOPPAN Holdings and Chiba University, and has run a large-scale data-health demonstration with Fukui Prefecture covering more than 4,000 residents.
1
Round
1
Industry
5
Tags
Oct 9, 2026
Latest raise
Funding activity · 1 round
Oct 9, 2026
JPY 570M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
